132 related articles for article (PubMed ID: 21509419)
1. Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008.
Cazzola M; Segreti A; Bettoncelli G; Calzetta L; Cricelli C; Pasqua F; Rogliani P
Prim Care Respir J; 2011 Sep; 20(3):291-8. PubMed ID: 21509419
[TBL] [Abstract][Full Text] [Related]
2. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
[TBL] [Abstract][Full Text] [Related]
3. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
[TBL] [Abstract][Full Text] [Related]
4. Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process.
Kardos P; Bechtel B; Palovis L; Hagedorn C; Latif F
Pneumologie; 2012 Sep; 66(9):549-57. PubMed ID: 22899206
[TBL] [Abstract][Full Text] [Related]
5. Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada.
Tavakoli H; Johnson KM; FitzGerald JM; Sin DD; Gershon AS; Kendzerska T; Sadatsafavi M
Int J Chron Obstruct Pulmon Dis; 2019; 14():2003-2013. PubMed ID: 31564848
[TBL] [Abstract][Full Text] [Related]
6. Fixed-Dose Combination Inhalers.
Cazzola M; Matera MG
Handb Exp Pharmacol; 2017; 237():117-129. PubMed ID: 27783268
[TBL] [Abstract][Full Text] [Related]
7. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
8. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
Ding B; Small M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Long-Acting Beta
Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
[TBL] [Abstract][Full Text] [Related]
10. Changed terms for drug payment influenced GPs' diagnoses and prescribing practice for inhaled corticosteroids.
Dalbak LG; Rognstad S; Melbye H; Straand J
Eur J Gen Pract; 2013 Jun; 19(2):106-10. PubMed ID: 23560809
[TBL] [Abstract][Full Text] [Related]
11. [Prescriptions for Asthma and COPD in Germany for the Years 2007, 2010, 2013, 2015 - 2017].
Hausen T
Pneumologie; 2019 Jun; 73(6):340-346. PubMed ID: 30895590
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate prescribing of combination inhalers in Northern Ireland: retrospective cross-sectional cohort study of prescribing practice in primary care.
Sweeney J; Patterson CC; O'Neill S; O'Neill C; Plant G; Lynch V; McAllister T; Heaney LG
Prim Care Respir J; 2014 Mar; 23(1):74-8. PubMed ID: 24570080
[TBL] [Abstract][Full Text] [Related]
13. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care.
Ding B; Small M; Scheffel G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2018; 13():927-936. PubMed ID: 29588581
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
[TBL] [Abstract][Full Text] [Related]
15. Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists.
Miller-Larsson A; Selroos O
Curr Pharm Des; 2006; 12(25):3261-79. PubMed ID: 17020533
[TBL] [Abstract][Full Text] [Related]
16. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
Petite SE
Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
[TBL] [Abstract][Full Text] [Related]
17. Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial.
Rottenkolber M; Fischer R; Ibáñez L; Fortuny J; Reynolds R; Amelio J; Gerlach R; Tauscher M; Thürmann P; Hasford J; Schmiedl S
BMC Pulm Med; 2015 May; 15():55. PubMed ID: 25943421
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.
Suissa S; Dell'Aniello S; Ernst P
Lancet Respir Med; 2018 Nov; 6(11):855-862. PubMed ID: 30343028
[TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
Chung KF; Caramori G; Adcock IM
Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics, treatment patterns, disease burden, and persistence/adherence in patients with asthma initiating inhaled triple therapy: real-world evidence from Japan.
Suzuki T; Fairburn-Beech J; Sato K; Kaise T
Curr Med Res Opin; 2020 Jun; 36(6):1049-1057. PubMed ID: 32363945
[No Abstract] [Full Text] [Related]
[Next] [New Search]
